Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Pulmonary Hypertension, June 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 209 articles:
HTML format


 

Single Articles

  1. WU LW, Chen M, Jiang DJ, Jiang CY, et al
    TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells.
    Respir Res. 2025;26:202.
    PubMed    
    Abstract available

  2. ZHANG X, Tao L, Yin X, Huang W, et al
    Long-term maternal and fetal outcomes of pulmonary hypertension in pregnancy in the southwest plateau area of China: a retrospective study.
    BMC Pulm Med. 2025;25:272.
    PubMed    
    Abstract available

  3. SHIRAZI SP, Negretti NM, Jetter CS, Sharkey AL, et al
    Bronchopulmonary dysplasia with pulmonary hypertension associates with semaphorin signaling loss and functionally decreased FOXF1 expression.
    Nat Commun. 2025;16:5004.
    PubMed    
    Abstract available

  4. WANG A, Pan Q, Zhang J, Gong S, et al
    Role of inflammation in endothelial responses in Pulmonary Hypertension.
    Biomed Pharmacother. 2025;188:118206.
    PubMed    
    Abstract available

  5. SZEWCZUK K, Dzikowska-Diduch O, Golebiowski M
    The use of imaging in the diagnosis and treatment of thromboembolic pulmonary hypertension.
    Cardiol J. 2025 May 29. doi: 10.5603/cj.102716.
    PubMed    
    Abstract available

  6. REDDY YNV, Frantz RP, Hassoun PM, Hemnes A, et al
    Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
    Circ Heart Fail. 2025 May 29:e012912. doi: 10.1161/CIRCHEARTFAILURE.125.012912.
    PubMed    
    Abstract available

  7. ZEESHAN M, Pearl GJ, Chakinala MM, Kotkar KD, et al
    Multidisciplinary Management and Staged Surgical Treatment for Chronic Thromboembolic Pulmonary Hypertension and Subclavian Vein Thrombosis Caused by Venous Thoracic Outlet Syndrome.
    Cureus. 2025;17:e84953.
    PubMed    
    Abstract available

  8. ZHANG R, Liu Z, Li R, Ai L, et al
    Construction and Validation of a Nomogram Model for Predicting Pulmonary Hypertension in Patients with Obstructive Sleep Apnea.
    Nat Sci Sleep. 2025;17:1049-1066.
    PubMed    
    Abstract available

  9. KATAGIRI J, Homma J, Takagi R, Sekine H, et al
    Intravenous mesenchymal stem cell transplantation mitigates pulmonary vascular remodeling but poses dose related risks in a pulmonary veno-occlusive disease model.
    Stem Cell Res Ther. 2025;16:258.
    PubMed    
    Abstract available

  10. LIN Y, Su Y, Cheng Z, Zhu B, et al
    Clinical Pharmacokinetics of Inhaled Drugs for Pulmonary Hypertension.
    Clin Pharmacokinet. 2025 May 28. doi: 10.1007/s40262-025-01525.
    PubMed    
    Abstract available

  11. GUO J, He J, Wang J, Liang Y, et al
    A novel nurse-led, multidisciplinary, and guideline-directed disease intensive management program improves long-term survival of pulmonary hypertension patients.
    Heart Lung. 2025;73:190-196.
    PubMed    
    Abstract available

  12. OROZCO-LEVI M, Londono A, Conde R, Gallego MCP, et al
    Pulmonary artery pressure assessed by catheterization and its concordance with transthoracic echocardiographic estimates in patients with pulmonary arterial hypertension: experience of the Colombian Pulmonary Hypertension Network in a real-life study.
    Crit Care Sci. 2025;37:e20250182.
    PubMed    
    Abstract available

  13. SONG R
    Attention to a Distinct Subtype of Pulmonary Hypertension: Methamphetamine-Associated Pulmonary Arterial Hypertension.
    Echocardiography. 2025;42:e70205.
    PubMed    


  14. CARTA AF, Saxer S, Mayer L, Schneider SR, et al
    Acute effect of acetazolamide on exercise haemodynamics in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension: a randomised controlled trial.
    ERJ Open Res. 2025;11:00782-2024.
    PubMed    
    Abstract available

  15. RATTANAKANOKCHAI S, Fungbun N, Senaphan K, Jitpean S, et al
    Evaluation of Plasma Nitric Oxide and Serum Endothelial Nitric Oxide Synthase in Pulmonary Hypertensive Dogs: A Clinical and Echocardiography Investigation.
    Vet Sci. 2025;12:486.
    PubMed    
    Abstract available

  16. MADONNA R, Ghelardoni S
    Sotatercept: A Crosstalk Between Pathways and Activities in the Pulmonary Circulation and Blood.
    Int J Mol Sci. 2025;26:4851.
    PubMed    
    Abstract available

  17. LEE HW, Huang CH, Chin CH, Chou PC, et al
    Changes in Pulmonary Hypertension Following Transcatheter Aortic Valve Implantation: Implications for Prognosis.
    J Clin Med. 2025;14:3463.
    PubMed    
    Abstract available

  18. AVCI BK, Basarici I, Akbulut M, Atas H, et al
    Comorbidity Burden in Chronic Thromboembolic Pulmonary Hypertension: Implications and Outcome.
    Medicina (Kaunas). 2025;61:827.
    PubMed    
    Abstract available

  19. GENG Y, Wang H, Bai Z, Ge R, et al
    Iron Replacement Attenuates Hypoxic Pulmonary Hypertension by Remodeling Energy Metabolism via Regulating the HIF2alpha/Mitochondrial Complex I, III/ROS Axis.
    Biomolecules. 2025;15:742.
    PubMed    
    Abstract available

  20. VAN WESTERING-KROON E, Hundscheid TM, Van Mechelen K, Bartos F, et al
    Sex differences in the risk of bronchopulmonary dysplasia and pulmonary hypertension: a Bayesian meta-analysis.
    Pediatr Res. 2025 May 27. doi: 10.1038/s41390-025-04145.
    PubMed    
    Abstract available

  21. HOPKINS S, Hall J, Saunders H, Bashir R, et al
    Sarcopenia in Patients with Chronic Thromboembolic Pulmonary Hypertension.
    J Cardiovasc Dev Dis. 2025;12:162.
    PubMed    
    Abstract available

  22. PAGNAMENTA S, Muller C, Meunier S, Dennler M, et al
    Transfusion related acute lung injury and associated transient pulmonary hypertension in a dog.
    Schweiz Arch Tierheilkd. 2025;167:352-360.
    PubMed    
    Abstract available

  23. ZHU XX, Zhao CY, Lu QB, Zhang AY, et al
    Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation.
    Front Pharmacol. 2025;16:1510275.
    PubMed    
    Abstract available

  24. SUN K, Guo F, Xu X, Liu Y, et al
    Case Report: a 28-year-old female with anomalous origin of the left coronary artery from the pulmonary artery syndrome presented as atrial fibrillation and pulmonary hypertension.
    Front Cardiovasc Med. 2025;12:1573539.
    PubMed    
    Abstract available

  25. STAAL DP, van Thor MCJ, Keijsers RGM, van Buul MMC, et al
    Assessment of perfusion on ventilation/perfusion scan after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: expert opinion versus guidance by reference chart.
    Nucl Med Commun. 2025 May 27. doi: 10.1097/MNM.0000000000001996.
    PubMed    
    Abstract available

  26. DA FONTOURA FF, Roncato G, Meyer GMB, da Luz Goulart C, et al
    Inspiratory Muscle Training on Exercise Capacity, Dyspnoea and Health Status in Pulmonary Hypertension: A Randomised Controlled Trial.
    Respirology. 2025 May 26. doi: 10.1111/resp.70054.
    PubMed    
    Abstract available

  27. KUMAR S, Kumar RK
    Common shunt lesions with pulmonary hypertension-who will benefit from surgery?
    Indian J Thorac Cardiovasc Surg. 2025;41:718-729.
    PubMed    
    Abstract available

  28. SHOAIBI A, Ostropolets A, Weaver J, Rao GA, et al
    Variation in Phenotype Definitions in Observational Clinical Research: A Review of Three Conditions.
    AMIA Annu Symp Proc. 2025;2024:1021-1029.
    PubMed    
    Abstract available

  29. DENG X, Qiu P, Li X, Hu Y, et al
    Potential of Sivelestat for Pulmonary Arterial Hypertension Treatment: Network Pharmacology-Based Target Identification and Mechanistic Exploration.
    Drug Des Devel Ther. 2025;19:4123-4138.
    PubMed    
    Abstract available

  30. CHEN X, Xu L, Shi H
    Emerging biomaterials and bio-nano interfaces in pulmonary hypertension therapy: transformative strategies for personalized treatment.
    Front Bioeng Biotechnol. 2025;13:1567783.
    PubMed    
    Abstract available

  31. SUGIMOTO K, Mochizuki Y, Itoi T, Tsuji K, et al
    Successful treatment of patent ductus arteriosus and severe pulmonary hypertension using sildenafil and beraprost sodium in two dogs.
    J Vet Med Sci. 2025 May 26. doi: 10.1292/jvms.25-0097.
    PubMed    
    Abstract available

  32. HAO X, Li H, Zeng Q, Cheng Z, et al
    Ero1a, the most strongly hypoxia-induced protein in PASMCs, promotes the development of hypoxia- and monocrotaline-induced pulmonary hypertension in rats.
    Life Sci. 2025;376:123754.
    PubMed    
    Abstract available

  33. NIU Q, Li Q, Chen S, Xiao L, et al
    First nomogram for predicting interstitial lung disease and pulmonary arterial hypertension in SLE: a machine learning approach.
    Respir Res. 2025;26:197.
    PubMed    
    Abstract available

  34. ARAUJO P, Cale R, Pereira E, Ferreira F, et al
    Balloon Pulmonary Angioplasty and riociguat in the management of chronic thromboembolic pulmonary hypertension: a systematic review.
    Respir Med. 2025 May 22:108154. doi: 10.1016/j.rmed.2025.108154.
    PubMed    
    Abstract available

  35. GUEST R, Dhaliwal D, Kinnear D, Kearney D, et al
    Lethal Neonatal Pulmonary Hypertension in Trisomy 21 (T21) Likely Due to Congenital Portosystemic Shunts.
    Pediatr Dev Pathol. 2025 May 24:10935266251343287.
    PubMed    
    Abstract available

  36. GUO Y, Zhao S, Zhang X, Gou R, et al
    Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension among PD patients.
    Int Urol Nephrol. 2025 May 23. doi: 10.1007/s11255-025-04580.
    PubMed    
    Abstract available

  37. SILVA CLM, Puthanveetil PN, Oliveira SD
    Liver bypass in the development of pathogen-associated pulmonary vascular disease: contribution of mesocaval and portosystemic shunts.
    Am J Physiol Gastrointest Liver Physiol. 2025;328:G791-G800.
    PubMed    
    Abstract available

  38. WAN C, Chen M, Tong J, Wang A, et al
    Prognostic effect of left ventricular-pulmonary arterial coupling indicator in pulmonary arterial hypertension.
    Int J Cardiol. 2025;434:133347.
    PubMed    
    Abstract available

  39. YILMAZ USTA D, Olgac S, Demirel MA, Kula S, et al
    Performance of oral Bosentan-loaded SNEDDS and S-SNEDDS tablets: Biodistribution in mice, echocardiography and histology studies in pulmonary arterial hypertension rat model.
    Eur J Pharm Biopharm. 2025;212:114725.
    PubMed    
    Abstract available

  40. PAOLI CJ, Zhang C, Tang X, Panjabi S, et al
    A real-world comparative effectiveness analysis of macitentan versus ambrisentan and bosentan on hospitalizations and healthcare resource utilization in patients with pulmonary arterial hypertension.
    Respir Med. 2025;243:108112.
    PubMed    
    Abstract available

  41. ANAND SC, Narowska G, Gangireddy C, Enevoldsen J, et al
    Novel automated electronic medical record-based VEST (virtual echocardiography screening tool) algorithm for pulmonary arterial hypertension.
    Am Heart J. 2025 Apr 5:S0002-8703(25)00102-4. doi: 10.1016/j.ahj.2025.
    PubMed    
    Abstract available

  42. DROMA Y, Ota M, Kobayashi N, Ito M, et al
    Genetic Associations with the Susceptibility to High-Altitude Pulmonary Edema in the Japanese Population.
    High Alt Med Biol. 2025;26:215-226.
    PubMed    
    Abstract available

  43. THOREAU B, Renaud A, Chafey P, Clary G, et al
    Anti-fibroblast and anti-endothelial cell autoantibodies in pulmonary arterial hypertension (PAH) in patients with connective tissue diseases (CTD).
    Rheumatology (Oxford). 2025;64:4041-4050.
    PubMed    
    Abstract available

  44. BJORKEKJAER HJ, Bruni C, Broch K, Brunborg C, et al
    A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis.
    Rheumatology (Oxford). 2025;64:3643-3656.
    PubMed    
    Abstract available

  45. SUN X, Zhang Y, Liu T, Zhang H, et al
    Clinical characteristics of primary SS- and overlap SS-associated pulmonary arterial hypertension: a multicentre retrospective study.
    Rheumatology (Oxford). 2025;64:3618-3625.
    PubMed    
    Abstract available

  46. MONTANI D
    [Pulmonary hypertension: 10 key messages].
    Rev Prat. 2025;75:65.
    PubMed    


  47. LACOSTE-PALASSET T, Jevnikar M, Jais X
    [Chronic thromboembolic pulmonary hypertension].
    Rev Prat. 2025;75:60-64.
    PubMed    
    Abstract available

  48. NOEL-SAVINA E, Turquier S, Chaouat A
    [Pulmonary hypertension associated with chronic lung diseas].
    Rev Prat. 2025;75:56-59.
    PubMed    
    Abstract available

  49. FAUVEL C, Lamia B, Lamblin N
    [Pulmonary hypertension due to left heart disease].
    Rev Prat. 2025;75:50-55.
    PubMed    
    Abstract available

  50. RIOU M, Salinas S, Sitbon O
    [Algorithm for the management of pulmonary arterial hypertension].
    Rev Prat. 2025;75:43-49.
    PubMed    
    Abstract available

  51. BOUCLY A, Pringuez H, Tromeur C
    [Screening and diagnosis of pulmonary hypertension].
    Rev Prat. 2025;75:36-42.
    PubMed    
    Abstract available

  52. LECHARTIER B, Jutant EM, Montani D
    [Revised definition and classification of pulmonary hypertension].
    Rev Prat. 2025;75:32-35.
    PubMed    
    Abstract available

  53. HUMBERT M, Simonneau G, Delcroix M
    [Consensus on pulmonary hypertension].
    Rev Prat. 2025;75:3.
    PubMed    


  54. TAN Y, Dai J, Ran B, Su Q, et al
    Pathogensis and treatments for high altitude pulmonary hypertension: an updated review.
    Am J Med Sci. 2025 Jun 3:S0002-9629(25)01067-5. doi: 10.1016/j.amjms.2025.
    PubMed    
    Abstract available

  55. GRAZIANO N, Gommeren K, Valcke A, Burnotte P, et al
    Retrospective evaluation of left ventricular eccentricity index in the assessment of precapillary pulmonary hypertension in dogs (2017-2021): 145 cases.
    Front Vet Sci. 2025;12:1548417.
    PubMed    
    Abstract available

  56. AKAO M, Kubota K, Miyanaga S, Mitsuyoshi K, et al
    A young man diagnosed with chronic thromboembolic pulmonary hypertension after COVID-19 infection: A case report.
    J Cardiol Cases. 2025;31:121-124.
    PubMed    
    Abstract available

  57. DING S, Deng Y, Hao L, Qiu W, et al
    Long-term outcome of CblC deficiency complicated with pulmonary hypertension.
    Orphanet J Rare Dis. 2025;20:276.
    PubMed    
    Abstract available

  58. COLMSEE H, Leuchte HH
    [Diagnosis and treatment of pulmonary hypertension].
    MMW Fortschr Med. 2025;167:56-63.
    PubMed    


  59. XIONG T, Li Y, Chen H, Jiang DS, et al
    Nuclear receptors in pulmonary hypertension: From pathophysiological mechanisms to clinical implications.
    Cytokine Growth Factor Rev. 2025 May 30:S1359-6101(25)00054.
    PubMed    
    Abstract available

  60. ABUDUKEREMU A, Aikemu A, Yang T, Fang L, et al
    Mechanism of ferroptosis in hypoxia-induced pulmonary vascular remodeling in hypoxia pulmonary hypertension: a study based on the ACE2-Ang-(1-7)-Mas axis.
    Chem Biol Interact. 2025 Jun 2:111596. doi: 10.1016/j.cbi.2025.111596.
    PubMed    
    Abstract available

  61. LEBAR K, Roth K, Liu W, Garcia B, et al
    Insights of right ventricular anisotropic hysteresis behavior with pulmonary hypertension development.
    Biomed Mater. 2025 Jun 4. doi: 10.1088/1748.
    PubMed    
    Abstract available

  62. YANG F, Yan Y, Jiang W, Wang Z, et al
    Impaired right atrial function preceding right ventricular systolic dysfunction: clinical utility and long-term prognostic value in pulmonary hypertension.
    Insights Imaging. 2025;16:115.
    PubMed    
    Abstract available

  63. MORA-CUESTA VM, Martinez-Menaca A, Iturbe-Fernandez D, Tello-Mena S, et al
    Lung Transplant Outcomes in Patients With Preoperative Catheterization Indicating Group 2 Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70107.
    PubMed    
    Abstract available

  64. YAN XD, Chen YY, Tao L
    [NDUFAF2 gene mutation presenting as primary pulmonary hypertension: a case report].
    Zhongguo Dang Dai Er Ke Za Zhi. 2025;27:609-612.
    PubMed    
    Abstract available

  65. KURONUMA K, Miyagi A, Takahashi K, Mukai T, et al
    Utility of Lung Volume-normalized SUV on Lung Perfusion SPECT in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Clin Nucl Med. 2025;50:623-630.
    PubMed    
    Abstract available

  66. RIUDOR GURI A, Luna Lopez R, Blanco I
    Arterial Tortuosity Syndrome: A Rare Cause of Pulmonary Hypertension.
    Arch Bronconeumol. 2025 Apr 28:S0300-2896(25)00143.
    PubMed    


  67. ZHENG YJ, Yuan PP, Zhang ZK, Liu YL, et al
    [Effects of total extract of Anthriscus sylvestris on immune inflammation and thrombosis in rats with pulmonary arterial hypertension based on TGF-beta1/Smad3 signaling pathway].
    Zhongguo Zhong Yao Za Zhi. 2025;50:2472-2483.
    PubMed    
    Abstract available

  68. LINDBERG L
    The rationale of using angiotensin receptor blocker instead of pulmonary vasodilators to treat pulmonary hypertension in bronchopulmonary dysplasia: a case report and literature review.
    Front Pediatr. 2025;13:1504180.
    PubMed    
    Abstract available

  69. XU J, Cui F, Zhang H
    Diagnose underlying diseases in patients with high probability of pulmonary hypertension by combined echocardiography.
    BMC Cardiovasc Disord. 2025;25:428.
    PubMed    
    Abstract available

  70. ABOU-ELMAGD T, Narechania S
    Should I start anticoagulation in my patient newly diagnosed with pulmonary hypertension?
    Cleve Clin J Med. 2025;92:339-343.
    PubMed    


  71. D'ARSIGNY CL
    Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension: What's age got to do with it?
    Can J Cardiol. 2025 May 31:S0828-282X(25)00376.
    PubMed    


  72. MALEV EG, Malikov KN, Goncharova NS, Simakova MA, et al
    [Echocardiography in the Diagnosis of Pulmonary Hypertension: From Basic to Advanced].
    Kardiologiia. 2025;65:58-69.
    PubMed    
    Abstract available

  73. TOKGOZ HC, Hakgor A, Tanyeri Uzel S, Kultursay B, et al
    Deep Dive into the Cardio-Pulmonary-Renal Interactions in Patients with Pulmonary Hypertension: Serum Creatinine Levels Even Within the Normal Range Related to Long-Term Survival.
    Anatol J Cardiol. 2025 May 29. doi: 10.14744/AnatolJCardiol.2025.3759.
    PubMed    
    Abstract available

  74. TAKAMA N, Ishibashi Y, Naidankhoo B, Ishio S, et al
    High Prevalence of Thyroid Gland Dysfunction after Pulmonary Arterial Hypertension Treatment According to Real-World Data.
    Int Heart J. 2025;66:443-448.
    PubMed    
    Abstract available

  75. ZHANG T, Jiang X, Diana C, Zhao X, et al
    YTHDF1-mediated m6A modification of TOP2A drives pulmonary hypertension via the PI3K/Akt/mTOR pathway.
    Cell Signal. 2025 May 30:111917. doi: 10.1016/j.cellsig.2025.111917.
    PubMed    
    Abstract available

  76. JEVNIKAR M, Montani D, Fadel E, Jais X, et al
    The evolution of management in chronic thromboembolic pulmonary hypertension in a non-surgical / balloon pulmonary angioplasty center.
    Respir Med Res. 2025;87:101043.
    PubMed    


  77. FLANAGAN LS, Sadek A, Oliveros E
    Vitamin C Deficiency as a Readily Reversible Cause of Pulmonary Hypertension.
    JACC Case Rep. 2025;30:103424.
    PubMed    
    Abstract available

  78. GENG Y, Hu Y, Wang H, Zhang F, et al
    Reduced iron bioavailability drives acute high?altitude lung injury through HIF1alpha activation and mitophagy.
    Mol Med Rep. 2025;32:215.
    PubMed    
    Abstract available

  79. ZHANG S, Gao L, Li S, Luo M, et al
    Association of Ambient Air Pollution With Invasive Pulmonary Hemodynamics and Long-Term Outcomes in Patients With Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2025;14:e039343.
    PubMed    
    Abstract available

  80. ROSEN DT, Kolb TM, Mathai SC, Suresh K, et al
    Dysregulated Tricarboxylic Acid Cycle Metabolism Is Associated With Right Ventricular Maladaptation in Pulmonary Vascular Disease.
    J Am Heart Assoc. 2025;14:e041127.
    PubMed    
    Abstract available

  81. ZHOU GX, Luo G, Pan SL
    [Progress in surgical treatment for pediatric pulmonary arterial hypertension].
    Zhonghua Er Ke Za Zhi. 2025;63:688-691.
    PubMed    


  82. SHAN L, Tang X, Liu Y, Qi W, et al
    Targeting BMPER as a therapeutic strategy for pulmonary arterial hypertension.
    Cell Signal. 2025;133:111880.
    PubMed    
    Abstract available

  83. FLORES CV, Chan SY
    Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape.
    Expert Opin Ther Targets. 2025;29:327-343.
    PubMed    
    Abstract available

  84. SUN Z, Jiang W, Lu G, Ding Y, et al
    Loss of ALDH2 accelerates the progression of pulmonary arterial hypertension through the 4-HNE/ERK1/2-p16(INK4a) signaling pathway.
    Biochim Biophys Acta Mol Basis Dis. 2025;1871:167863.
    PubMed    
    Abstract available

  85. TANG H, Ning K, Wu B, Wang X, et al
    Scutellarein ameliorates pulmonary arterial hypertension via sirtuin 1 mediated deacetylation of nicotinamide nucleotide transhydrogenase.
    Biochem Pharmacol. 2025;237:116932.
    PubMed    
    Abstract available

  86. NOWAK S, Jaffuel D, Morel J, Ahmed E, et al
    Phenotypes and prognosis of systemic sclerosis: A cluster analysis.
    Respir Med Res. 2025;87:101168.
    PubMed    
    Abstract available

  87. KAWASAKI H, Nakabayashi K, Ikeda M, Onda T, et al
    Familial Alveolar Capillary Dysplasia With Misalignment of Pulmonary Veins Caused by Paternal FOXF1 Upstream Enhancer Deletion: A Case Report.
    Am J Med Genet A. 2025;197:e64056.
    PubMed    
    Abstract available

  88. NI R, Xie M, Zhang J, Zhong M, et al
    Expression and Predictive Value of Angiopoietin-2 in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.
    COPD. 2025;22:2512749.
    PubMed    
    Abstract available

  89. LIU Z, Mo L, Cao W, Wang K, et al
    Global, regional, and national trends in pulmonary arterial hypertension burden, 1990-2021: findings from the global burden of disease study 2021.
    Front Public Health. 2025;13:1516365.
    PubMed    
    Abstract available

  90. ALBULUSHI A, El-Sharnouby K, Soror K, Alhajri N, et al
    GLP-1 receptor agonists and pulmonary hypertension in diabetes: A promising therapeutic strategy.
    Am Heart J Plus. 2025;55:100555.
    PubMed    
    Abstract available

  91. ABEER F, Wani AA, Javid B, Mahmood A, et al
    Severe Early-Onset Pulmonary Hypertension in a Six-Month-Old With Down Syndrome and Isolated Secundum Atrial Septal Defect.
    Cureus. 2025;17:e84019.
    PubMed    
    Abstract available

  92. YAMADA K, Satoh T, Yaoita N, Chiba N, et al
    CTRP7 as a molecular biomarker associating with responsiveness to pulmonary vasodilators: insights from human and animal studies in pulmonary arterial hypertension.
    Cardiovasc Res. 2025;121:929-942.
    PubMed    
    Abstract available

  93. ZHAO H, Ma X, Chen P, Liu B, et al
    Enhanced Spatial Transcriptomics Analysis of Mouse Lung Tissues Reveals Cell-Specific Gene Expression Changes Associated with Pulmonary Hypertension.
    J Respir Biol Transl Med. 2025;2:10004.
    PubMed    
    Abstract available

  94. VILLARREAL ES, Marinho Y, Loya O, Aboagye SY, et al
    Endothelial c-IAP2 Loss Amplifies P2X7 Receptor-Driven Inflammation and Worsens Infection-Associated Pulmonary Hypertension.
    bioRxiv [Preprint]. 2025 May 27:2025.05.22.655387.
    PubMed    
    Abstract available


  95. Correction to "Treatment Approaches for Pulmonary Hypertension in Colombia: A Call to Action".
    Clin Respir J. 2025;19:e70148.
    PubMed    


  96. STARK ASL, Rawlings GH, Gregory JD, Armstrong I, et al
    A randomized controlled trial of self-help cognitive behavioural therapy for depression in adults with pulmonary hypertension.
    Br J Health Psychol. 2025;30:e12800.
    PubMed    
    Abstract available

  97. MCNAIR BD, Satyanarayana SB, Matthews JM, Polson SM, et al
    Incomplete reverse remodeling in pulmonary hypertension-induced right ventricular dysfunction in aged mice.
    Physiol Rep. 2025;13:e70422.
    PubMed    
    Abstract available

  98. EKICI M, Sari A, Armagan B, Unaldi E, et al
    Patients with suspected pulmonary hypertension based on echocardiography in Behcet's disease: a 5-year follow-up study.
    Orphanet J Rare Dis. 2025;20:299.
    PubMed    
    Abstract available

  99. SULTAN D, Brundel BJJM, Kurakula K
    The Interplay Between Pulmonary Hypertension and Atrial Fibrillation: A Comprehensive Overview.
    Cells. 2025;14:839.
    PubMed    
    Abstract available

  100. CHEN G, Pollak M
    New-Onset Mania With Psychotic Features in a Patient With DiGeorge Syndrome, HIV, Syphilis, and Pulmonary Hypertension.
    Cureus. 2025;17:e83883.
    PubMed    
    Abstract available

  101. GUO Y, Gao Z, Zhang R, Long H, et al
    Neutrophil-Endothelium Interaction Mediated by S100A9 Promotes Pulmonary Vascular Remodeling During Pulmonary Hypertension.
    Adv Sci (Weinh). 2025 Jun 10:e04397. doi: 10.1002/advs.202504397.
    PubMed    
    Abstract available

  102. LEIVA O, Soo S, Smilowitz NR, Reynolds H, et al
    Impact of Echocardiographic Probability of Pulmonary Hypertension on Prognosis and Outcomes Among Patients With Myeloproliferative Neoplasms.
    Circ Cardiovasc Imaging. 2025 Jun 10:e017986.
    PubMed    
    Abstract available

  103. DASGUPTA S
    TFF3 Gene as a Molecular Target Potentially Shared by Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension: Drug Repurposing Prospect with Aminoglutethimide.
    OMICS. 2025 Jun 10. doi: 10.1089/omi.2025.0066.
    PubMed    
    Abstract available

  104. JIANG Q, Wen D, Peng F, Hong W, et al
    Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis.
    J Vis Exp. 2025;.
    PubMed    
    Abstract available

  105. LI D, Wang C, Su Z, Ma J, et al
    Hypobaric hypoxia promotes the production of IL-10 of lung NKT cells in HAPE rats to fight inflammation.
    Exp Lung Res. 2025;51:38-49.
    PubMed    
    Abstract available

  106. CUI TT, Guo XX, Chen M
    [Advances in pulmonary hypertension related to chronic hemolytic anemia].
    Zhonghua Nei Ke Za Zhi. 2025;64:571-576.
    PubMed    


  107. WANG Z, Wang Q, Xu H, Zhang H, et al
    Pulmonary hypertension induced right heart failure via upregulation of serum Dickkopf-1 expression.
    Int J Cardiol. 2025;437:133481.
    PubMed    
    Abstract available

  108. YANG J, Liu J, Gu H, Song W, et al
    Gut microbiota, metabolites, and pulmonary hypertension: Mutual regulation and potential therapies.
    Microbiol Res. 2025;299:128245.
    PubMed    
    Abstract available

  109. KIM J, Choi YS, Kim J, Wahab R, et al
    Targeted delivery of apelin using a novel extracellular vesicle platform for pulmonary arterial hypertension treatment.
    Biomaterials. 2025;323:123438.
    PubMed    
    Abstract available

  110. WAHAB R, Keshavarz A, Azam Z, Islam T, et al
    Microfluidic captured patient-derived circulating endothelial cells identify novel targets of pulmonary arterial hypertension.
    Biomaterials. 2025;323:123429.
    PubMed    
    Abstract available

  111. KIRK ME, Dragsbaek SJ, Merit VT, Lyhne MD, et al
    Cardiopulmonary remodeling following repetitive acute pulmonary emboli and inhibition of endogenous fibrinolysis in a porcine model.
    Int J Cardiol. 2025 May 17:133398. doi: 10.1016/j.ijcard.2025.133398.
    PubMed    
    Abstract available

  112. HUANG S, Qiu J, Wang A, Ma Y, et al
    Burden of pulmonary arterial hypertension in Asia from 1990 to 2021: Findings from Global Burden of Disease Study 2021.
    Chin Med J (Engl). 2025;138:1324-1333.
    PubMed    
    Abstract available

  113. IGARASHI-SUGIMOTO A, Tsujino I, Shima H, Nakamura J, et al
    Reduced hemoglobin-corrected diffusing capacity in pulmonary arterial hypertension with preserved pulmonary function and morphology.
    Respir Investig. 2025;63:600-607.
    PubMed    
    Abstract available

  114. GU S, Kopecky BJ, Pena B, Vagnozzi RJ, et al
    Sex-dependent Pathophysiology and Therapeutic Considerations in Right Heart Disease.
    Can J Cardiol. 2025;41:1038-1053.
    PubMed    
    Abstract available

  115. LI J, Zhou Y, Shu T, Lei W, et al
    Differentiation of lung tissue-resident c-Kit(+) cells into microvascular endothelial cells alleviates pulmonary vascular remodeling.
    Dev Cell. 2025;60:1601-1617.
    PubMed    
    Abstract available

  116. TASCA S, Turck P, Drosdowski D, Campos Carraro C, et al
    Melatonin improves adverse vascular remodelling and redox homeostasis in monocrotaline-induced pulmonary arterial hypertension.
    Arch Physiol Biochem. 2025;131:455-466.
    PubMed    
    Abstract available

  117. CHENG LH, Sun X, Elliot C, Condliffe R, et al
    Mean pulmonary artery pressure prediction with explainable multi-view cardiovascular magnetic resonance cine series deep learning model.
    J Cardiovasc Magn Reson. 2025;27:101133.
    PubMed    
    Abstract available

  118. GENECAND L, Simian G, Lichtblau M, Fellrath JM, et al
    The Impact of Cardiac Output Methods on the Classification of Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70112.
    PubMed    
    Abstract available

  119. CHEN Y, Li J, Qiao Q, Zhou Y, et al
    Intravascular ultrasound evaluation of pulmonary hypertension in high-altitude patients with ventricular septal defect: a case report.
    J Med Case Rep. 2025;19:284.
    PubMed    
    Abstract available

  120. HUANG Y, Yang T, Liang X, Chen Y, et al
    Global, regional and national trends in the burden of persistent pulmonary hypertension of the newborn and essentials of its management from 1993 to 2023: a scoping review.
    Front Pediatr. 2025;13:1502385.
    PubMed    
    Abstract available

  121. HAN MZ, Wang Y, Sun KX, Zhang YJ, et al
    Upregulating vascular endothelial K(Ca)2.3 channels alleviates pulmonary hypertension in mice.
    Mol Pharmacol. 2025;107:100048.
    PubMed    
    Abstract available

  122. RIOS G, Perez-Rios N
    Association of 6-Minute Walk Test (6MWT) Data with Cardiopulmonary Factors in Hispanic Systemic Sclerosis Patients.
    P R Health Sci J. 2025;44:111-115.
    PubMed    
    Abstract available

  123. HUANG X, Fan R, Lu Y, Yu C, et al
    Correction: Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies.
    Mol Biol Rep. 2025;52:609.
    PubMed    


  124. MOTSCHWILLER C, Morales D, Sulica R
    Connective tissue disease-related interstitial lung disease and pulmonary hypertension.
    Breathe (Sheff). 2025;21:240173.
    PubMed    
    Abstract available

  125. RAWLINGS GH, Stark A, Armstrong I, Costin V, et al
    The Role of Psychological Distress on Health-Related Quality of Life, Fatigue, and Pain in Adults With Pulmonary Hypertension.
    Pulm Circ. 2025;15:e70101.
    PubMed    
    Abstract available

  126. LIU CY, Wang H, Jing ZC
    [Anxiety and depression in patients with pulmonary hypertension].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2025;53:708-712.
    PubMed    


  127. SINGH E, Bisserier M
    Experimental animal models and patient-derived platforms to bridge preclinical discovery and translational therapeutics in pulmonary arterial hypertension.
    J Transl Med. 2025;23:665.
    PubMed    
    Abstract available

  128. DURBIN MD, Tingay DG, Kua KL
    Deciphering epigenetic control of Notch signaling in persistent pulmonary hypertension of the newborn.
    Pediatr Res. 2025 Jun 17. doi: 10.1038/s41390-025-04234.
    PubMed    


  129. SILBERKASTEN M, San Martin E, Cuello JV, Britto MV, et al
    Pulmonary hypertension secondary to vitamin C deficiency: A case report.
    Arch Argent Pediatr. 2025 Jun 19:e202510643. doi: 10.5546/aap.2025-10643.
    PubMed    
    Abstract available

  130. TAWA M, Abe S, Fujita A, Ando R, et al
    Beneficial effects of magnesium nitrate on disease severity in male rats with monocrotaline-induced pulmonary hypertension.
    Physiol Rep. 2025;13:e70416.
    PubMed    
    Abstract available

  131. RISCHARD FP, Hemnes AR
    Right Ventricular Function, Inflammation, and the Gut Microbiome in Pulmonary Hypertension: A Translational Frontier.
    Circ Heart Fail. 2025 Jun 17:e013198. doi: 10.1161/CIRCHEARTFAILURE.125.013198.
    PubMed    


  132. LANCELLOTTI P, Budts W, Vachiery JL
    Echocardiographic practices in pulmonary hypertension: survey results and literature review.
    Acta Cardiol. 2025 Jun 17:1-4. doi: 10.1080/00015385.2025.2518645.
    PubMed    


  133. HUANG X, Balasubramanian A, Moutchia J, Williams K, et al
    Ambient Air Pollution Exposure and Mortality in the Pulmonary Hypertension Association Registry.
    Ann Am Thorac Soc. 2025 Jun 16. doi: 10.1513/AnnalsATS.202501.
    PubMed    
    Abstract available

  134. KALTSOGIANNI O, Bhat R, Greenough A, Dassios T, et al
    Tachycardia and persistent pulmonary hypertension of the newborn.
    Front Pediatr. 2025;13:1607907.
    PubMed    
    Abstract available

  135. LEONG ZP
    A pilot study investigating renal biomarkers in dogs with pulmonary hypertension: a comparison between cystatin-C, symmetric dimethylarginine, and creatinine.
    J Vet Med Sci. 2025 Jun 13. doi: 10.1292/jvms.25-0034.
    PubMed    
    Abstract available

  136. TEMPLE FT, Simonova G, Passmore MR, Foley SR, et al
    Storage duration of packed red blood cells transfused during veno-venous extracorporeal membrane oxygenation is associated with elevated pulmonary artery pressure and lung injury in a sheep model.
    Crit Care. 2025;29:240.
    PubMed    
    Abstract available

  137. MARASCO E, Dusing C, Keymel S, Bortoluzzi A, et al
    Pulmonary arterial hypertension in systemic lupus erythematosus: identification of risk factors and haemodynamics characteristics in a multicentre retrospective cohort.
    Lupus Sci Med. 2025;12:e001471.
    PubMed    
    Abstract available

  138. ZHENG X, Zhao J, Jia X, Pan J, et al
    Fucoxanthin Ameliorates Vascular Remodeling via Attenuating Oxidative Stress in Hypoxic Pulmonary Hypertension Rats.
    J Nutr Biochem. 2025 Jun 11:110002. doi: 10.1016/j.jnutbio.2025.110002.
    PubMed    
    Abstract available

  139. LI M, Hao Y, Song X, Liu H, et al
    ca-circSCN8A Promotes HPASMCs Ferroptosis via LLPS Initiated R-Loop.
    Hypertension. 2025;82:e114-e128.
    PubMed    
    Abstract available

  140. RAMANI G, Bali V, Black H, Bond D, et al
    Exploring the Economic Burden of Pulmonary Arterial Hypertension and Its Relation to Disease Severity and Treatment Escalation: A Systematic Literature Review.
    Pharmacoeconomics. 2025;43:741-760.
    PubMed    
    Abstract available

  141. SU X, Sun Y, Dai A
    New insights into pulmonary arterial hypertension: interaction between PANoptosis and perivascular inflammatory responses.
    Apoptosis. 2025;30.
    PubMed    
    Abstract available

  142. KLEPPINGER C, Ivy D, Stockbridge N, Bates A, et al
    Procedural Variation May Contribute to 6-Minute Walk Distance Variability in Real-World Pediatric Pulmonary Arterial Hypertension Study.
    AAPS J. 2025;27:114.
    PubMed    
    Abstract available

  143. AMIN SR, Loo EZ, Almazedi B, Bowker A, et al
    Selective embolisation for renal arteriovenous fistula-induced pulmonary hypertension.
    BMJ Case Rep. 2025;18:e265669.
    PubMed    
    Abstract available

  144. SEKII R, Kato S, Nakayama N, Fukui K, et al
    Atrial Septal Defect With Right-to-Left Shunt Without Pulmonary Hypertension: Diagnosis Through Multimodality Imaging.
    JACC Case Rep. 2025;30:103853.
    PubMed    
    Abstract available

  145. VLACHAKIS PK, Nyktari E, Apostolos A, Theofilis P, et al
    Segmental Pulmonary Hypertension in Complex Congenital Heart Disease: The Role of Multimodality Imaging.
    JACC Case Rep. 2025;30:104249.
    PubMed    
    Abstract available

  146. YANG Y, Gong S, Liang N, Li Z, et al
    The role of histone modifications in pulmonary hypertension: From mechanisms to therapeutic targets.
    Vascul Pharmacol. 2025 Jun 25:107519. doi: 10.1016/j.vph.2025.107519.
    PubMed    
    Abstract available

  147. MENDOZA-ZAMBRANO E, Ballaz-Quincoces A, Lobo JL, Gomez-Cuervo C, et al
    Identification of phenotypes and predictors for dyspnea, echocardiographic probability of pulmonary hypertension, and confirmed CTEPH in patients with acute pulmonary embolism: Analysis of two large patient cohorts.
    Thromb Res. 2025;252:109379.
    PubMed    


  148. PATHAN M, Kido K, Kamal KM
    Cost analysis of a clinical pharmacist-led multidisciplinary iron deficiency treatment clinic for patients with heart failure or pulmonary hypertension.
    Am J Health Syst Pharm. 2025 Jun 19:zxaf113. doi: 10.1093.
    PubMed    
    Abstract available

  149. OTOMI Y, Otsuka H, Kasai R, Morishita J, et al
    The clinical utility of ventilation-perfusion scintigraphy in the classification of pulmonary hypertension.
    Jpn J Radiol. 2025 Jun 27. doi: 10.1007/s11604-025-01822.
    PubMed    
    Abstract available

  150. BISHOP RS, Doan TT, Lara C, Eilers LF, et al
    Echo-Derived Right Ventricular Strain Identifies Pulmonary Hypertension in Pediatric Ventricular Assist Device Patients.
    ASAIO J. 2025 Jun 27. doi: 10.1097/MAT.0000000000002489.
    PubMed    
    Abstract available

  151. ZHANG H, Yan M, Li F, Chen Q, et al
    Exercise-Induced Oxygen Desaturation and Heart Rate Response During 6-Min Walk Test Predict Pulmonary Hypertension in Exertional Dyspnea: A Retrospective Cohort Study.
    Pulm Circ. 2025;15:e70120.
    PubMed    
    Abstract available

  152. XIE Z, Chen Y, Xie J, Lei Y, et al
    Mechanistic Insight into the Enhanced Anti-Pulmonary Hypertension Efficacy of Wogonin Co-Amorphous.
    Pharmaceutics. 2025;17:724.
    PubMed    
    Abstract available

  153. PILIERO N, Salvat M, Bertoletti L, Bouvaist H, et al
    Iron deficiency in chronic thromboembolic pulmonary hypertension referred for balloon pulmonary angioplasty.
    Respir Med. 2025 Jun 24:108219. doi: 10.1016/j.rmed.2025.108219.
    PubMed    
    Abstract available

  154. GARCIA-HERNANDEZ ML, Rangel-Moreno J, Xu Q, Jeong YJ, et al
    TNF drives aberrant BMP signaling to induce endothelial and mesenchymal dysregulation in pulmonary hypertension.
    JCI Insight. 2025 Jun 26:e174456. doi: 10.1172/jci.insight.174456.
    PubMed    
    Abstract available

  155. LI S, Gao L, Zhang S, Zhao Q, et al
    Association of Systemic Inflammatory Response Index with Disease Severity and Adverse Outcome in Chronic Thromboembolic Pulmonary Hypertension.
    J Inflamm Res. 2025;18:8217-8231.
    PubMed    
    Abstract available

  156. PARKER C, Whalen E, Smith MA, Becerra J, et al
    Anxiety and Depression Screening of Youth in Pediatric Pulmonary Hypertension Clinic: A Multi-Center, Cross-Sectional Study.
    Pulm Circ. 2025;15:e70117.
    PubMed    
    Abstract available

  157. MAHAJAN A, Chandran S, Kumar A, Chen L, et al
    LncRNA-536 and RNA-Binding Protein RBM25 Interactions in Pulmonary Artery Smooth Muscle Cells: Implications in Pulmonary Hypertension.
    Arterioscler Thromb Vasc Biol. 2025 Jun 26. doi: 10.1161/ATVBAHA.125.322734.
    PubMed    
    Abstract available

  158. CHENG Y, Tian YN, Huang M, Xu JP, et al
    [Hydrogen sulfide ameliorates hypoxic pulmonary hypertension in rats by inhibiting aerobic glycolysis-pyroptosis].
    Sheng Li Xue Bao. 2025;77:465-471.
    PubMed    
    Abstract available

  159. NIKLAS K, Sikorska D, Mularek-Kubzdela T, Witoszynska-Sobkowiak J, et al
    Antibody Profile of Systemic Sclerosis and Mixed Connective Tissue Disease and Its Relationship with Lung Fibrosis and Pulmonary Hypertension.
    Int J Mol Sci. 2025;26:5684.
    PubMed    
    Abstract available

  160. MENDOZA-ZAMBRANO E, Sanchez-Lopez V, Gomez-Rodriguez B, Garcia-Lunar I, et al
    Role of Extracellular Vesicles in Chronic Post-Embolic Pulmonary Hypertension: Data from an Experimental Animal Model and Patients.
    Biomedicines. 2025;13:1499.
    PubMed    
    Abstract available

  161. YEH FC, Tsai IT, Chyuan IT
    Molecular Pathogenesis of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension: A Narrative Review.
    Biomolecules. 2025;15:772.
    PubMed    
    Abstract available

  162. MASUDA T, Akita K, Sato R, Ikoma T, et al
    The Efficacy and Safety of Outpatient Exercise Training for Patients with Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty.
    J Cardiovasc Dev Dis. 2025;12:216.
    PubMed    
    Abstract available

  163. CHEN ZW, Li YF, Qiu HL, Xie W, et al
    Maternal Electronic Cigarette Exposure Induces Dysregulation of Autophagy via Oxidative Stress/DNA Methylation in Pulmonary Hypertension Offspring.
    Curr Med Sci. 2025 Jun 24. doi: 10.1007/s11596-025-00074.
    PubMed    
    Abstract available

  164. EGENLAUF B, Braun M, Schiffer V, Marra AM, et al
    Right ventricular function in pulmonary hypertension and obesity: a cross-sectional cohort study with survival follow-up.
    Clin Res Cardiol. 2025 Jun 24. doi: 10.1007/s00392-025-02682.
    PubMed    
    Abstract available

  165. ABDULAAL L, Maiter A, Dwivedi K, Sharkey MJ, et al
    Lung parenchymal and cardiac appearances on computed tomography pulmonary angiography impact survival in chronic thromboembolic pulmonary hypertension: results from the ASPIRE Registry.
    ERJ Open Res. 2025;11:00732-2024.
    PubMed    
    Abstract available

  166. OH SB, Jeon YK, Choi N, Yoo HY, et al
    Effects of in vivo treatment with K(v)7.4 activator, URO-K10, on the impaired relaxation of pulmonary arteries in the monocrotaline-induced pulmonary hypertensive rats.
    Korean J Physiol Pharmacol. 2025;29:475-485.
    PubMed    
    Abstract available

  167. GOLDIN G, Mombeini H, Mercurio V, Hsu S, et al
    Innovating the Gold Standard: The Emerging Role of Echocardiographic Stress Testing in the Classification, Stratification, and Prognostication in Pulmonary Vascular Disease.
    Curr Cardiol Rep. 2025;27:100.
    PubMed    
    Abstract available

  168. REHMAN R, Dieffenbach P, Vellarikkal SK, Corcoran AM, et al
    PINK1/Parkin Deficiency Enhances Vascular Remodeling and Aggravates Hypoxia-induced Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2025 Jun 23. doi: 10.1165/rcmb.2024-0349.
    PubMed    
    Abstract available

  169. SIMPKIN CT, Frank BS, Liu Y, Pan Z, et al
    Echocardiographic Prediction of Hemodynamics During Acute Vasoreactivity Testing in Pediatric Pulmonary Arterial Hypertension.
    Echocardiography. 2025;42:e70232.
    PubMed    
    Abstract available

  170. ZHOU J, Xu Z, Peng DB, Li X, et al
    Macrophage-Derived LCN2 Promotes Methamphetamine-Induced Pulmonary Hypertension.
    Hypertension. 2025 Jun 23. doi: 10.1161/HYPERTENSIONAHA.124.24548.
    PubMed    
    Abstract available

  171. VALIZADEH P, Jannatdoust P, Shojaei S, Mousavi A, et al
    The diagnostic performance of dual-energy CT in detecting chronic thromboembolic pulmonary hypertension: A systematic-review and Meta-analysis.
    Clin Imaging. 2025;125:110552.
    PubMed    
    Abstract available

  172. STUDLEY WR, Lamanna E, Nold-Petry CA, Qin CX, et al
    Insights from precision-cut lung slices-investigating mechanisms and therapeutics for pulmonary hypertension.
    Respir Res. 2025;26:220.
    PubMed    
    Abstract available

  173. SWISHER JW, Weaver E
    Therapeutic options for patients with pulmonary hypertension and interstitial lung disease.
    Ther Adv Respir Dis. 2025;19:17534666251335815.
    PubMed    
    Abstract available

  174. SMITH CF, Ding KL, Seedorf GJ, Galambos C, et al
    Postnatally induced TBX4 insufficiency confers pulmonary hypertension and impairs lung development in infant mice.
    Pediatr Res. 2025 Jun 20. doi: 10.1038/s41390-025-04127.
    PubMed    
    Abstract available

  175. ALTURAIF N, Attanasio U, Mercurio V
    Pulmonary arterial hypertension: sex-specific differences and outcomes.
    Ther Adv Respir Dis. 2025;19:17534666251350493.
    PubMed    
    Abstract available

  176. DUBROCK H, Small M, Scott M, Harley J, et al
    Clinical characteristics, treatment patterns and healthcare resource utilisation for portopulmonary hypertension patients in the USA: a real-world study.
    BMJ Open. 2025;15:e089223.
    PubMed    
    Abstract available

  177. KACHABI A, Altieri Correa S, Chesler NC, Colebank MJ, et al
    Bayesian parameter inference and uncertainty quantification for a computational pulmonary hemodynamics model using Gaussian processes.
    Comput Biol Med. 2025;194:110552.
    PubMed    
    Abstract available

  178. WEBER SC, Alvensleben IV, Vadiunec V, Iben A, et al
    Ebstein Repair in a High-Altitude Setting >/=2,500 m: First Experience from Bolivia.
    Thorac Cardiovasc Surg. 2025;73.
    PubMed    
    Abstract available

  179. KIM NH, Chin KM, McLaughlin VV, Ong R, et al
    Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS.
    Adv Ther. 2025;42:3306-3333.
    PubMed    
    Abstract available

  180. COBER ND, Chaudhary KR, Deng Y, Lee CJ, et al
    Single-cell microencapsulation improves lung retention of endothelial colony-forming cells after intravascular delivery and unmasks therapeutic benefit in severe pulmonary arterial hypertension.
    Cytotherapy. 2025;27:723-732.
    PubMed    
    Abstract available

  181. BIONDI F, Alberti M, Montemaggi E, D'Alleva A, et al
    Not just CTEPH: a narrative review on the spectrum approach to post pulmonary embolism conditions.
    Thromb Haemost. 2024 Sep 19. doi: 10.1055/a-2418-7895.
    PubMed    
    Abstract available

  182. PUTORTI F, Fabris T, Strosio M, Mesiani C, et al
    Computed Tomography Scan Predictors and Prognostic Impact of Combined Pulmonary Hypertension in Patients with Aortic Valve Stenosis undergoing TAVI.
    Am J Cardiol. 2025 Jun 3:S0002-9149(25)00344.
    PubMed    
    Abstract available

  183. LEWIS CV, Nguyen TN, Porfilio TE, Burciaga SD, et al
    Vascular EC-SOD limits the accumulation, proinflammatory profibrotic reprogramming, and hyaluronan binding of interstitial macrophages in hypoxia.
    Am J Physiol Lung Cell Mol Physiol. 2025;328:L885-L900.
    PubMed    
    Abstract available

  184. MORA MASSAD K, Dai Z, Petrache I, Ventetuolo CE, et al
    Lung endothelial cell heterogeneity in health and pulmonary vascular disease.
    Am J Physiol Lung Cell Mol Physiol. 2025;328:L877-L884.
    PubMed    
    Abstract available

  185. GONYEA CR, Shen Y, Nelson KM, Bird RN, et al
    The nitrofen/bisdiamine murine model of congenital diaphragmatic hernia has a pulmonary hypertension vascular phenotype consistent with human CDH.
    Am J Physiol Lung Cell Mol Physiol. 2025 May 30. doi: 10.1152/ajplung.00233.2024
    PubMed    
    Abstract available

  186. IMAKIIRE S, Kimuro K, Yoshida K, Masaki K, et al
    Activated Factor X Inhibition Ameliorates NF-kappaB-IL-6?Mediated Perivascular Inflammation and Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2025 Jun 13. doi: 10.1152/ajplung.00303.2024
    PubMed    
    Abstract available

  187. HARBAUM L, Klose H, Wilkins MR
    From Blood to Vessel: Lipid Ratios in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed    


  188. LIU S, Shan X, Sun Y, Chen H, et al
    Deficient FANCL Predisposes Endothelial Damage: A New Therapeutic Target for Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed    
    Abstract available

  189. ROTHMAN AMK, Villar SS, Middleton J, Roussakis AA, et al
    Positioning Imatinib for Pulmonary Arterial Hypertension: A Dose-Finding Phase 2 Study.
    Am J Respir Crit Care Med. 2025;211:1018-1027.
    PubMed    
    Abstract available

  190. MONTANI D, McLaughlin VV, Gibbs JSR, Gomberg-Maitland M, et al
    Consistent Safety and Efficacy of Sotatercept for Pulmonary Arterial Hypertension in BMPR2 Mutation Carriers and Noncarriers: A Planned Analysis of a Phase II, Double-Blind, Placebo-controlled Clinical Trial (PULSAR).
    Am J Respir Crit Care Med. 2025;211:1028-1037.
    PubMed    
    Abstract available

  191. NATHAN SD, Kim HC, King CS, Aryal S, et al
    Serial Pulmonary Hemodynamics in Patients with Idiopathic Pulmonary Fibrosis Listed for Lung Transplant.
    Am J Respir Crit Care Med. 2025;211:984-991.
    PubMed    
    Abstract available

  192. SIMOES DE JESUS D, Buffonge S, Abis G, Buccafusca R, et al
    Zinc-mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2025.
    PubMed    
    Abstract available

  193. NAIDU SR, Desai AA
    A Peek into Pulmonary Hypertension Through the Plasma Proteome.
    Am J Respir Crit Care Med. 2025 Jun 26. doi: 10.1164/rccm.202505-1063.
    PubMed    


  194. CASSADY SJ, Gladwin MT
    The Mirage of Individualized Therapy in the United States: Barriers in Pulmonary Hypertension Due to Sickle Cell Disease & Sarcoidosis.
    Am J Respir Crit Care Med. 2025 Jun 26. doi: 10.1164/rccm.202411-2126.
    PubMed    


  195. WHITE RJ, El-Kersh K, Rosenkranz S, Franco V, et al
    Treatment with Oral or Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities.
    Chest. 2024 Nov 30:S0012-3692(24)05604-6. doi: 10.1016/j.chest.2024.
    PubMed    
    Abstract available

  196. HUANG Z, Diao X, Huo Y, Zhao Z, et al
    Deep Learning-Enhanced Non-Invasive Detection of Pulmonary Hypertension and Subtypes via Chest Radiographs, Validated by Catheterization.
    Chest. 2025 Jun 18:S0012-3692(25)00702-0. doi: 10.1016/j.chest.2025.
    PubMed    
    Abstract available

  197. MEI J, Huang W, Meng Z, Wen S, et al
    Super-Enhancer-Driven HCG20 Promotes Pulmonary Hypertension Through U2AF2 Splicing.
    Circ Res. 2025 May 28. doi: 10.1161/CIRCRESAHA.125.326133.
    PubMed    
    Abstract available

  198. AGUADO B, Grynblat J, Budhram B, Ghigna MR, et al
    Pulmonary veno-occlusive disease: a paradigm of diagnosis and therapeutic challenges in pulmonary hypertension.
    Curr Opin Pulm Med. 2025 Jun 6. doi: 10.1097/MCP.0000000000001184.
    PubMed    
    Abstract available

  199. TAGARIELLO F, Elia D, Harari SA
    Rare pulmonary diseases and pulmonary hypertension.
    Curr Opin Pulm Med. 2025 Jun 27. doi: 10.1097/MCP.0000000000001188.
    PubMed    
    Abstract available

  200. NAEIJE R, Chaouat A, Pinsky MR
    Viewpoint: a critique of pulmonary vascular resistance to define severe pulmonary hypertension.
    Eur Respir J. 2025;65:2500409.
    PubMed    


  201. LANG IM, Brenot P, Bouvaist H, Fadel E, et al
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Results of an International Multicenter Prospective Registry.
    J Am Coll Cardiol. 2025;85:2270-2284.
    PubMed    
    Abstract available

  202. NAKATA C, Goda A, Takeuchi K, Takeuchi S, et al
    Prevalence of Occult HFpEF and Age-Specific Efficacy of Passive Leg Raise in Pulmonary Hypertension.
    J Heart Lung Transplant. 2025 May 28:S1053-2498(25)01954.
    PubMed    
    Abstract available

  203. ALVES-JR JL, Costa ELV, Hoette S, Fernandes CJCDS, et al
    Right ventricular-pulmonary arterial coupling in schistosomiasis associated pulmonary arterial hypertension.
    J Heart Lung Transplant. 2025;44:1024-1032.
    PubMed    
    Abstract available

  204. PYA Y, Bekbossynova M, Medressova A, Latremouille C, et al
    Precise monitoring of transpulmonic resistance in bridge-to-transplant patients supported by the Aeson total artificial heart.
    J Heart Lung Transplant. 2025;44:1161-1164.
    PubMed    
    Abstract available

  205. HUMBERT M, McLaughlin VV, Badesch DB, Ghofrani HA, et al
    Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
    N Engl J Med. 2025 Mar 31. doi: 10.1056/NEJMoa2415160.
    PubMed    
    Abstract available

  206. NATHAN SD
    Early phase clinical trials in pulmonary hypertension: how small is big enough?
    Thorax. 2025 Jun 1:thorax-2025-223535. doi: 10.1136/thorax-2025-223535.
    PubMed    


  207. CZEPIEL K, Nagy N, Panjalingam T, Kalinowski A, et al
    Randomised, placebo-controlled trial of oral hymecromone in adults with pulmonary hypertension.
    Thorax. 2025 Jun 1:thorax-2024-222725. doi: 10.1136/thorax-2024-222725.
    PubMed    
    Abstract available

  208. SONG Y, Li F, Xie W, Zhao L, et al
    Is it truly chronic thromboembolic pulmonary hypertension? A case of pulmonary hypertension with proptosis.
    Thorax. 2025 Jun 15:thorax-2024-222953. doi: 10.1136/thorax-2024-222953.
    PubMed    


  209. BERREBEH N, Mbouamboua Y, Thuillet R, Ottaviani M, et al
    Bone morphogenetic protein-9 controls pulmonary vascular growth and remodeling.
    Proc Natl Acad Sci U S A. 2025;122:e2410229122.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;